Ostomy, wound care and hospital products
ConvaTec is a leading developer and marketer of innovative
medical technologies. With four key business divisions: Advanced
Wound Care, Ostomy Care, Continence and Critical Care (CCC)
and Infusion Devices, ConvaTec products support health care
professionals from the hospital to the community health setting.
The company has operations in over 100 countries serving consumers
and health care professionals on six continents.
Nordic Capital Funds VI and VII acquired a majority shareholding
in ConvaTec from Bristol Myers Squibb in August 2008. Since then,
the company has grown to become one of the leading medical
technology companies globally, with a strong focus on structurally
growing chronic care markets and sales to patients and healthcare
professionals in more than 100 countries.
During Nordic Capital's ownership, the company has benefited
from ongoing operational improvements, organic growth and
complementary acquisitions. Key acquisitions include Unomedical, a
leading manufacturer of single-use medical devices based in
Copenhagen, which was also backed by Nordic Capital; and 180
Medical, through which ConvaTec distributes intermittent urological
catheters directly to patients in the United States. Since Nordic
Capital's initial investment in 2008, ConvaTec's number of
employees has almost trebled and the company now employs circa
ConvaTec Group Plc was listed on the London Stock Exchange in
October 2016. Together, Nordic Capital Funds VI and VII, remain the
largest shareholder in ConvaTec after the listing.
- Paul Moraviec, CEO
- Nigel Clerkin, CFO